Access the full text.
Sign up today, get DeepDyve free for 14 days.
Forse Ra, B. Karam, L. Maclean, Christou Nv (1989)
Antibiotic prophylaxis for surgery in morbidly obese patients.Surgery, 106 4
D. Greenblatt, D. Abernethy, A. Locniskar, J. Harmatz, R. Limjuco, R. Shader (1984)
Effect of Age, Gender, and Obesity on Midazolam KineticsAnesthesiology, 61
J. Yee, Stephen Duffull (2000)
The effect of body weight on dalteparin pharmacokinetics A preliminary studyEuropean Journal of Clinical Pharmacology, 56
W. James (1977)
Research on obesity.Nutrition reviews, 35 9
Abernethy (1984)
Am J Gastroenterol, 79
L. Bauer, R. Blouin, W. Griffen, K. Record, Richard Bell (1980)
Amikacin pharmacokinetics in morbidly obese patients.American journal of hospital pharmacy, 37 4
H. Mann, H. Buchwald (1986)
Cefamandole Distribution in Serum, Adipose Tissue, and Wound Drainage in Morbidly Obese PatientsAnnals of Pharmacotherapy, 20
U. Buchholz, C. Richards, Rekha Murthy, M. Arduino, D. Pon, Wayne Schwartz, Elsie Fontanilla, C. Pegues, Noemy Boghossian, C. Peterson, Jacob Kool, L. Mascola, W. Jarvis (2000)
Pyrogenic Reactions Associated With Single Daily Dosing of Intravenous GentamicinInfection Control & Hospital Epidemiology, 21
P. Christoff, D. Conti, C. Naylor, W. Jusko (1983)
Procainamide Disposition in Obesity, 17
Cheymol (1997)
Br J Clin Pharmacol, 43
F. Pühringer, C. Keller, A. Kleinsasser, S. Giesinger, A. Benzer (2000)
Pharmacokinetics of Rocuronium Bromide in Obese Female Patients
M. Kovacs, M. Kovacs, K. Weir, K. Mackinnon, M. Keeney, W. Brien, M. Cruickshank, M. Cruickshank (1998)
Body weight does not predict for anti-Xa levels after fixed dose prophylaxis with enoxaparin after orthopedic surgery.Thrombosis research, 91 3
E. Gonzalez (1990)
Pharmacokinetics of ranitidine in morbidly obese women.Dicp-The annals of pharmacotherapy, 24
L. Bauer, W. Edwards, E. Dellinger, D. Simonowitz (2004)
Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patientsEuropean Journal of Clinical Pharmacology, 24
B. Zarowitz, A. Petitta, M. Rudis, H. Horst, R. Hyzy (1996)
Bar Code Documentation of Pharmacotherapy Services in Intensive Care UnitsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 16
Klem (1994)
Crit Care Med, 22
Abernethy (1984)
Am J Cardiol, 53
D. MacGregor, Timothy Smith, R. Prielipp, J. Butterworth, R. James, P. Scuderi (2000)
Pharmacokinetics of Dopamine in Healthy Male SubjectsAnesthesiology, 92
J. Barrett, E. Gibiansky, R. Hull, A. Planès, H. Pentikis, J. Hainer, T. Hua, M. Gastonguay (2009)
Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis.International journal of clinical pharmacology and therapeutics, 39 10
P. Gal, W. Jusko, A. Yurchak, B. Franklin (1978)
Theophylline disposition in obesityClinical Pharmacology & Therapeutics, 23
C. Rand, J. Kuldau, R. Yost (1985)
Obesity and post-operative pain.Journal of psychosomatic research, 29 1
D. Roden (1993)
Pharmacokinetics of amiodarone: implications for drug therapy.The American journal of cardiology, 72 16
Wilson (2001)
Haemostasis, 31
W. Young, M. Bracken (1990)
The Second National Acute Spinal Cord Injury Study.Journal of neurotrauma, 9 Suppl 1
Blouin (1982)
Antimicrob Agents Chemother, 21
G. Cheymol (2000)
Effects of Obesity on PharmacokineticsClinical Pharmacokinetics, 39
Schwartz (1992)
Anesth Analg, 74
S. Wilson, K. Wilbur, Erica Burton, D. Anderson (2001)
Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous ThromboembolismPathophysiology of Haemostasis and Thrombosis, 31
R. Blouin, H. Mann, W. Griffen, L. Bauer, K. Record (1979)
Tobramycin pharmacokinetics in morbidly obese patientsClinical Pharmacology & Therapeutics, 26
Steinberg (1994)
Clin Pharmacokinet, 27
Kovacs (1998)
Thromb Res, 91
Davis (1990)
DICP Ann Pharmacother, 24
D. Abernethy, D. Greenblatt, R. Matlis, R. Gugler (1984)
Cimetidine disposition in obesity.The American journal of gastroenterology, 79 2
Bauer (1998)
Eur J Clin Pharmacol, 54
Abernethy (1988)
J Cardiovasc Pharmacol, 11
Raschke (1993)
Ann Intern Med, 119
Rand (1999)
J Psychosom Res, 29
Yost (1986)
Ther Drug Monit, 8
D. Abernethy, D. Greenblatt, M. Divoll, J. Harmatz, R. Shader (1981)
Alterations in drug distribution and clearance due to obesity.The Journal of pharmacology and experimental therapeutics, 217 3
M.H.S. Roubenoff, J. Kehayias (2009)
The meaning and measurement of lean body mass.Nutrition reviews, 49 6
Tsikouris (2001)
Pharmacotherapy, 21
D. Abernethy, D. Greenblatt, T. Smith (1981)
Digoxin disposition in obesity: clinical pharmacokinetic investigation.American heart journal, 102 4
C. Steinberg, D. Notterman (1994)
Pharmacokinetics of Cardiovascular Drugs in ChildrenClinical Pharmacokinetics, 27
Bauer (1980)
Am J Hosp Pharm, 37
D. Abernethy, D. Greenblatt (1985)
Phenytoin disposition in obesity. Determination of loading dose.Archives of neurology, 42 5
Abernethy (1981)
J Pharmacol Exp Ther, 217
R. Bennett, R. Batenhorst, D. Graves, T. Foster, W. Griffen, B. Wright (1982)
Variation in Postoperative Analgesic Requirements in the Morbidly Obese Following Gastric Bypass SurgeryPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2
M. Chow (1996)
Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use.The Annals of pharmacotherapy, 30 6
F. Pühringer, C. Keller, A. Kleinsasser, S. Giesinger, A. Benzer (1999)
Pharmacokinetics of rocuronium bromide in obese female patients.European journal of anaesthesiology, 16 8
Gal (1978)
Clin Pharmacol Ther, 23
Chow (1996)
Ann Pharmacother, 30
Robin Davis, R. Quenzer, H. Bozigian, C. Warner (1990)
Pharmacokinetics of Ranitidine in Morbidly Obese WomenAnnals of Pharmacotherapy, 24
W. Pories, A. rij, B. Burlingham, R. Fulghum, D. Meelheim (1981)
Prophylactic cefazolin in gastric bypass surgery.Surgery, 90 2
C. Klem, J. Dasta, T. Reilley, L. Flancbaum (1994)
Variability in dobutamine pharmacokinetics in unstable critically ill surgical patientsCritical Care Medicine, 22
Cheymol (1987)
J Clin Pharmacol, 27
T. Dunn, E. Ludwig, R. Slaughter, D. Camara, W. Jusko (1991)
Pharmacokinetics and pharmacodynamics of methylprednisolone in obesityClinical Pharmacology & Therapeutics, 49
U. Priglinger, G. Karth, A. Geppert, C. Joukhadar, S. Graf, R. Berger, M. Hülsmann, S. Spitzauer, I. Pabinger, G. Heinz (2003)
Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?*Critical Care Medicine, 31
G. Cheymol, J. Poirier, P. Carrupt, B. Testa, J. Weissenburger, J. Levron, E. Snoeck (1997)
Pharmacokinetics of β-adrenoceptor blockers in obese and normal volunteersBritish Journal of Clinical Pharmacology, 43
Hacke (1995)
JAMA, 274
J. Robinson, Stefan Lupkiewicz, Lisa Palenik, Larry Lopez, Mario Ariet (1983)
Determination of ideal body weight for drug dosage calculations.American journal of hospital pharmacy, 40 6
A. Schwartz, R. Matteo, E. Ornstein, J. Halevy, J. Diaz (1992)
Pharmacokinetics and Pharmacodynamics of Vecuronium in the Obese Surgical PatientAnesthesia & Analgesia, 74
S. Allard, M. Kinzig, G. Boivin, F. Sörgel, M. Lebel (1993)
Intravenous ciprofloxacin disposition in obesityClinical Pharmacology & Therapeutics, 54
L. Bauer, D. Black, J. Lill (1998)
Vancomycin dosing in morbidly obese patientsEuropean Journal of Clinical Pharmacology, 54
D. Abernethy, D. Greenblatt (1984)
Lidocaine disposition in obesity.The American journal of cardiology, 53 8
M. Bracken, M. Shepard, T. Holford, L. Leo‐Summers, E. Aldrich, M. Fazl, M. Fehlings, D. Herr, P. Hitchon, L. Marshall, R. Nockels, V. Pascale, P. Perot, J. Piepmeier, V. Sonntag, F. Wagner, J. Wilberger, H. Winn, W. Young (1997)
Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury Results of the Third National Acute Spinal Cord Injury Randomized Controlled TrialJAMA, 277
Abernethy (1985)
Arch Neurol, 42
F. Varin, J. Ducharme, Y. Théorêt, J. Besner, D. Bevan, F. Donati (1990)
Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracuriumClinical Pharmacology & Therapeutics, 48
G. Houghton, A. Richens, M. Leighton (1975)
Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients.British journal of clinical pharmacology, 2 3
D. Cullen, B. Sweitzer, D. Bates, E. Burdick, A. Edmondson, L. Leape (1997)
Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units.Critical care medicine, 25 8
G. Cheymol, J. Poirier, J. Barré, A. Pradalier, J. Dry (1987)
Comparative Pharmacokinetics of Intravenous Propranolol in Obese and Normal VolunteersThe Journal of Clinical Pharmacology, 27
MacGregor (2000)
Anesthesiology, 92
M. McCarron, B. Devine (1974)
Clinical Pharmacy: Case Studies, 8
Roubenoff (1991)
Nutrition Rev, 49
J. Tsikouris, Alexander Tsikouris (2001)
A Review of Available Fibrin‐Specific Thrombolytic Agents Used in Acute Myocardial InfarctionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 21
Forse (1989)
Surgery, 106
B. Zahorska‐Markiewicz, M. Waluga, M. Zieliński, M. Klin (1996)
Pharmacokinetics of theophylline in obesity.International journal of clinical pharmacology and therapeutics, 34 9
F. Servin, R. Farinotti, J. Haberer, J. Desmonts (1993)
Propofol Infusion for Maintenance of Anesthesia in Morbidly Obese Patients Receiving Nitrous Oxide A Clinical and Pharmacokinetic StudyANESTHESIOLOGY, 78
R. Raschke, B. Reilly, J. Guidry, J. Fontana, S. Srinivas (1993)
The Weight-based Heparin Dosing Nomogram Compared with a Standard Care NomogramAnnals of Internal Medicine, 119
Ellison (1989)
Clin Pharm, 8
W. Hacke, M. Kaste, C. Fieschi, D. Toni, E. Lesaffre, R. Kummer, G. Boysen, E. Bluhmki, G. Höxter, M. Mahagne (1995)
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 274 13
Christoff (1983)
Drug Intell Clin Pharm, 17
J. Caldwell, A. Nilsen (1994)
Intravenous Ciprofloxacin Dosing in a Morbidly Obese PatientAnnals of Pharmacotherapy, 28
R. Blouin, L. Bauer, D. Miller, K. Record, W. Griffen (1982)
Vancomycin pharmacokinetics in normal and morbidly obese subjectsAntimicrobial Agents and Chemotherapy, 21
Abernethy (1981)
Am Heart J, 102
J. Grotta, M. Kothari, K. Welch, J. Broderick, B. Tilley, T. Brott, Marler, P. Lyden, P. O'Byrne (1995)
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.The New England Journal of Medicine
Zahorska-Markiewicz (1996)
Int J Clin Pharmacol Ther, 34
Beth Duplaga, Christina Rivers, E. Nutescu (2001)
Dosing and Monitoring of Low‐Molecular‐Weight Heparins in Special PopulationsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 21
J. Kampmann, H. Klein, B. Lumholtz, J. Hansen (1984)
Ampicillin and Propylthiouracil Pharmacokinetics in Intestinal Bypass Patients Followed Up to a Year after OperationClinical Pharmacokinetics, 9
Buchholz (2000)
Infect Control Hosp Epidemiol, 21
G. Bernard, J. Vincent, P. Laterre, S. LaRosa, J. Dhainaut, A. Lopez-Rodriguez, J. Steingrub, G. Garber, J. Helterbrand, E. Ely, C. Fisher (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.The New England journal of medicine, 344 10
The (1995)
N Engl J Med, 333
D. Abernethy, J. Schwartz (1988)
Verapamil pharmacodynamics and disposition in obese hypertensive patients.Journal of cardiovascular pharmacology, 11 2
Puhringer (1999)
Eur J Anaesthesiol, 16
T. Egan, B. Huizinga, Samir Gupta, R. Jaarsma, R. Sperry, J. Yee, K. Muir (1998)
Remifentanil Pharmacokinetics in Obese versus Lean PatientsAnesthesiology, 89
M. Ellison, W. Sawyer, T. Mills (1989)
Calculation of heparin dosage in a morbidly obese woman.Clinical pharmacy, 8 1
R. Yost, H. Derendorf (1986)
Disposition of cefotaxime and its desacetyl metabolite in morbidly obese male and female subjects.Therapeutic drug monitoring, 8 2
Diane Becker, Claude Bouchard, Richard Carleton, William Dietz, J. Foreyt, Scott Grundy, S. Kumanyika, Elaine Prewitt, A. Rocchini, Philip Smith, Linda Snetselaar, James Sowers, David Williamson, Karen Donato, Michael Horan, V. Hubbard, Clarice Brown (1998)
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults.WMJ : official publication of the State Medical Society of Wisconsin, 97 9
AM Traynor, A. Nafziger, Jr Bertino (1995)
Aminoglycoside dosing weight correction factors for patients of various body sizesAntimicrobial Agents and Chemotherapy, 39
ObjectiveTo derive recommendations for the dosing of commonly used medications in the morbidly obese patient in the ICU.Data sourcesArticles were obtained through computerized searches involving MEDLINE. The bibliographies of retrieved publications and textbooks were reviewed for additional references.Study selectionAll studies involving the pharmacokinetics or pharmacodynamics of medications in obese subjects or patients.Data extractionThe emphasis was on studies involving morbidly obese patients but, in the absence of such data, investigations involving lesser forms of obesity were extracted.Data synthesisThere is a paucity of data upon which to make recommendations for dosing commonly used medications in the morbidly obese patient in the ICU, although recommendations were provided based on the available information.ConclusionsThere is clearly a need for more investigations involving dosing regimens of medications in the morbidly obese population. Until such studies are available, the clinician must try to derive the best dosing regimens for medications based on the limited pharmacokinetic data available for some agents and clinical judgement.
Intensive Care Medicine – Springer Journals
Published: Jan 1, 2004
Keywords: Morbid obesity; Dosing; Pharmacokinetics; Intensive care
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.